These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18848572)

  • 41. A mathematical approach to molecular organization and proteolytic disintegration of bacterial inclusion bodies.
    Cubarsi R; Carrió MM; Villaverde A
    Math Med Biol; 2005 Sep; 22(3):209-26. PubMed ID: 15781425
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mass spectrometric methodologies for the analysis of biotechnologically produced protein pharmaceuticals.
    Malorni A
    Farmaco; 1992 May; 47(5 Suppl):723-40. PubMed ID: 1524622
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A minimal input-output configuration for a priori identifiability of a compartmental model of leucine metabolism.
    Saccomani MP; Cobelli C
    IEEE Trans Biomed Eng; 1993 Aug; 40(8):797-803. PubMed ID: 8258446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Taguchi methodology as a statistical tool for biotechnological applications: a critical appraisal.
    Rao RS; Kumar CG; Prakasham RS; Hobbs PJ
    Biotechnol J; 2008 Apr; 3(4):510-23. PubMed ID: 18320563
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DAISY: a new software tool to test global identifiability of biological and physiological systems.
    Bellu G; Saccomani MP; Audoly S; D'Angiò L
    Comput Methods Programs Biomed; 2007 Oct; 88(1):52-61. PubMed ID: 17707944
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Digital image processing as a tool to monitor biomass growth in Aspergillus niger 3T5B8 solid-state fermentation: preliminary results.
    Couri S; Mercês EP; Neves BC; Senna LF
    J Microsc; 2006 Dec; 224(Pt 3):290-7. PubMed ID: 17210061
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Review: To be or not to be an identifiable model. Is this a relevant question in animal science modelling?
    Muñoz-Tamayo R; Puillet L; Daniel JB; Sauvant D; Martin O; Taghipoor M; Blavy P
    Animal; 2018 Apr; 12(4):701-712. PubMed ID: 29096725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identifiability of parameters and behaviour of MCMC chains: a case study using the reaction norm model.
    Shariati MM; Korsgaard IR; Sorensen D
    J Anim Breed Genet; 2009 Apr; 126(2):92-102. PubMed ID: 19320765
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The structural identifiability of the susceptible infected recovered model with seasonal forcing.
    Evans ND; White LJ; Chapman MJ; Godfrey KR; Chappell MJ
    Math Biosci; 2005 Apr; 194(2):175-97. PubMed ID: 15854675
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Global robustness and identifiability of random, scale-free, and small-world networks.
    Gong Y; Zhang Z
    Ann N Y Acad Sci; 2009 Mar; 1158():82-92. PubMed ID: 19348634
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimization of acetic acid production from synthesis gas by chemolithotrophic bacterium--Clostridium aceticum using statistical approach.
    Sim JH; Kamaruddin AH
    Bioresour Technol; 2008 May; 99(8):2724-35. PubMed ID: 17697778
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quality-by-design for biotechnology-related pharmaceuticals.
    Mandenius CF; Graumann K; Schultz TW; Premstaller A; Olsson IM; Petiot E; Clemens C; Welin M
    Biotechnol J; 2009 May; 4(5):600-9. PubMed ID: 19418475
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modeling of purification operations in biotechnology: enabling process development, optimization, and scale-up.
    Velayudhan A; Menon MK
    Biotechnol Prog; 2007; 23(1):68-73. PubMed ID: 17269673
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Symmetry, identifiability, and prediction uncertainties in multistage clonal expansion (MSCE) models of carcinogenesis.
    Cox LA; Huber WA
    Risk Anal; 2007 Dec; 27(6):1441-53. PubMed ID: 18093045
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimal synthesis of protein purification processes.
    Vásquez-Alvarez E; Lienqueo ME; Pinto JM
    Biotechnol Prog; 2001; 17(4):685-96. PubMed ID: 11485430
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new process for acrylic acid synthesis by fermentative process.
    Lunelli BH; Duarte ER; Vasco de Toledo EC; Wolf Maciel MR; Maciel Filho R
    Appl Biochem Biotechnol; 2007 Apr; 137-140(1-12):487-99. PubMed ID: 18478411
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A confidence building exercise in data and identifiability: Modeling cancer chemotherapy as a case study.
    Eisenberg MC; Jain HV
    J Theor Biol; 2017 Oct; 431():63-78. PubMed ID: 28733187
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biotechnological routes to pyruvate production.
    Xu P; Qiu J; Gao C; Ma C
    J Biosci Bioeng; 2008 Mar; 105(3):169-75. PubMed ID: 18397764
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimization strategies based on sequential quadratic programming applied for a fermentation process for butanol production.
    Pinto Mariano A; Bastos Borba Costa C; de Franceschi de Angelis D; Maugeri Filho F; Pires Atala DI; Wolf Maciel MR; Maciel Filho R
    Appl Biochem Biotechnol; 2009 Nov; 159(2):366-81. PubMed ID: 19082763
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    Kirk JA; Saccomani MP; Shroff SG
    Cardiovasc Eng Technol; 2013 Dec; 4(4):500-512. PubMed ID: 26726299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.